| scholarly article | Q13442814 |
| P356 | DOI | 10.1515/BC.2008.026 |
| P698 | PubMed publication ID | 18177263 |
| P50 | author | Romano Regazzi | Q56946155 |
| P2093 | author name string | Pascal Lovis | |
| Sonia Gattesco | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| exocytosis | Q323426 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 305-312 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | Biological Chemistry | Q4914948 |
| P1476 | title | Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs | |
| P478 | volume | 389 |
| Q38555259 | A rare SNP in pre-miR-34a is associated with increased levels of miR-34a in pancreatic beta cells |
| Q36811697 | Affection of single-nucleotide polymorphisms in miR-27a, miR-124a, and miR-146a on susceptibility to type 2 diabetes mellitus in Chinese Han people |
| Q36906371 | Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction |
| Q35087718 | Analysis of synaptic-like microvesicle exocytosis of B-cells using a live imaging technique |
| Q34117281 | Beta-cell specific deletion of Dicer1 leads to defective insulin secretion and diabetes mellitus. |
| Q38999205 | Biological roles of microRNAs in the control of insulin secretion and action |
| Q37372564 | CHO microRNA engineering is growing up: recent successes and future challenges |
| Q36047577 | Changes in microRNA expression contribute to pancreatic β-cell dysfunction in prediabetic NOD mice |
| Q37467545 | Chronic reduction of the cytosolic or mitochondrial NAD(P)-malic enzyme does not affect insulin secretion in a rat insulinoma cell line |
| Q55422940 | Circulating miRNAs as Predictive Biomarkers of Type 2 Diabetes Mellitus Development in Coronary Heart Disease Patients from the CORDIOPREV Study. |
| Q34065655 | Classical Renin-Angiotensin system in kidney physiology |
| Q98735775 | Comparative microRNA Transcriptomes in Domestic Goats Reveal Acclimatization to High Altitude |
| Q34532789 | Comparative microRNA expression profiles of cynomolgus monkeys, rat, and human reveal that mir-182 is involved in T2D pathogenic processes |
| Q50433123 | Connexins and microRNAs: Interlinked players in regulating islet function? |
| Q35794964 | DICER Inactivation Identifies Pancreatic β-Cell "Disallowed" Genes Targeted by MicroRNAs. |
| Q37855088 | Diabetes mellitus, a microRNA-related disease? |
| Q35925909 | Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic β- and α-Cells. |
| Q36380597 | Down regulation of miR-124 in both Werner syndrome DNA helicase mutant mice and mutant Caenorhabditis elegans wrn-1 reveals the importance of this microRNA in accelerated aging |
| Q34155071 | Drosophila miR-14 regulates insulin production and metabolism through its target, sugarbabe |
| Q38038647 | Emerging roles of non-coding RNAs in pancreatic β-cell function and dysfunction |
| Q28073039 | Epigenetics and Cellular Metabolism |
| Q26823288 | Epigenetics: the missing link to understanding β-cell dysfunction in the pathogenesis of type 2 diabetes |
| Q59801792 | Exercise Training-Induced Changes in MicroRNAs: Beneficial Regulatory Effects in Hypertension, Type 2 Diabetes, and Obesity |
| Q39207341 | Exocytosis proteins as novel targets for diabetes prevention and/or remediation? |
| Q28744044 | Expression and localization of microRNAs in perinatal rat pancreas: role of miR-21 in regulation of cholesterol metabolism |
| Q24609213 | Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis |
| Q34094840 | Function of microRNA-375 and microRNA-124a in pancreas and brain |
| Q58799369 | Functional implications of Rab27 GTPases in Cancer |
| Q55207759 | Genome-wide Profiling of Urinary Extracellular Vesicle microRNAs Associated With Diabetic Nephropathy in Type 1 Diabetes. |
| Q21136357 | High glucose suppresses human islet insulin biosynthesis by inducing miR-133a leading to decreased polypyrimidine tract binding protein-expression |
| Q36009702 | High-Throughput Sequencing Reveals Circulating miRNAs as Potential Biomarkers for Measuring Puberty Onset in Chicken (Gallus gallus). |
| Q34908066 | Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription |
| Q52689984 | Identification of miR-9 as a negative factor of insulin secretion from beta cells. |
| Q39127739 | Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes |
| Q37374078 | Increased expression of miR-187 in human islets from individuals with type 2 diabetes is associated with reduced glucose-stimulated insulin secretion |
| Q36004106 | Induction of miR-132 and miR-212 Expression by Glucagon-Like Peptide 1 (GLP-1) in Rodent and Human Pancreatic β-Cells |
| Q36236480 | Induction of miR-96 by Dietary Saturated Fatty Acids Exacerbates Hepatic Insulin Resistance through the Suppression of INSR and IRS-1. |
| Q26865641 | Influence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetes |
| Q48794491 | Involvement of MicroRNAs in Diabetes and Its Complications |
| Q33750755 | Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. |
| Q43555794 | Long-term disruption of maternal glucose homeostasis induced by prenatal glucocorticoid treatment correlates with miR-29 upregulation. |
| Q59337332 | Mapping the Pax6 3' untranslated region microRNA regulatory landscape |
| Q36764809 | Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades |
| Q99712011 | MiR-124a Regulates Extracellular Vesicle Release by Targeting GTPase Rabs in Lung Cancer |
| Q45424255 | MiR-335 overexpression impairs insulin secretion through defective priming of insulin vesicles. |
| Q49907062 | MiRNA-binding site variants of type 2 diabetes candidate loci predispose to gestational diabetes mellitus in Chinese Han women. |
| Q37578248 | MiRNAs in β-Cell Development, Identity, and Disease. |
| Q58923883 | MicroRNA genetic variations: association with type 2 diabetes |
| Q54959769 | MicroRNA, Proteins, and Metabolites as Novel Biomarkers for Prediabetes, Diabetes, and Related Complications. |
| Q37413876 | MicroRNA-124 promotes hepatic triglyceride accumulation through targeting tribbles homolog 3. |
| Q92467659 | MicroRNA-124: An emerging therapeutic target in cancer |
| Q35057752 | MicroRNA-185 targets SOCS3 to inhibit beta-cell dysfunction in diabetes |
| Q34797485 | MicroRNA-206 regulates surfactant secretion by targeting VAMP-2. |
| Q93364981 | MicroRNA-296-5p promotes healing of diabetic wound by targeting sodium-glucose transporter 2 (SGLT2) |
| Q47148014 | MicroRNA-34c acts as a bidirectional switch in the maturation of insulin-producing cells derived from mesenchymal stem cells |
| Q37039063 | MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy |
| Q28547296 | MicroRNAs 9 and 370 Association with Biochemical Markers in T2D and CAD Complication of T2D |
| Q38184973 | MicroRNAs and human diseases: diagnostic and therapeutic potential |
| Q26824024 | MicroRNAs as pharmacological targets in diabetes |
| Q38595212 | MicroRNAs as regulators of beta-cell function and dysfunction |
| Q37567440 | MicroRNAs as regulators of death receptors signaling |
| Q36290327 | MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity |
| Q39008865 | MicroRNAs in Type 1 Diabetes: Complex Interregulation of the Immune System, β Cell Function and Viral Infections. |
| Q30400205 | MicroRNAs in adipogenesis and as therapeutic targets for obesity |
| Q27023327 | MicroRNAs in insulin resistance and obesity |
| Q37088373 | MicroRNAs in metabolic disease |
| Q33612997 | MicroRNAs in metabolism and metabolic disorders |
| Q38038648 | MicroRNAs in pancreas development |
| Q38150359 | MicroRNAs in the onset and development of cardiovascular disease |
| Q35063263 | MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications |
| Q27028201 | MicroRNAs: a new ray of hope for diabetes mellitus |
| Q49332519 | Micromanaging Glucose Tolerance and Diabetes |
| Q34603046 | Minireview: microRNA function in pancreatic β cells |
| Q44798827 | Modulation of hsa-miR-26b levels following adipokine stimulation |
| Q37243359 | Molecular medicine of microRNAs: structure, function and implications for diabetes. |
| Q39064013 | Mutant p53 regulates Dicer through p63-dependent and -independent mechanisms to promote an invasive phenotype |
| Q38360373 | Noncoding RNAs in β cell biology |
| Q38233063 | Novel approaches to drug discovery for the treatment of type 2 diabetes |
| Q37176911 | Novel aspects of the molecular mechanisms controlling insulin secretion |
| Q30433325 | Novel mechanisms for the control of renin synthesis and release |
| Q35003838 | Nutritionally-induced catch-up growth |
| Q47322426 | Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men. |
| Q27028039 | Post-transcriptional regulation in metabolic diseases |
| Q37308227 | Potential regulatory functions of microRNAs in the ovary |
| Q27027043 | Rab27 GTPases distribute extracellular nanomaps for invasive growth and metastasis: implications for prognosis and treatment |
| Q38266502 | Regulation of Pancreatic Beta Cell Stimulus-Secretion Coupling by microRNAs. |
| Q37415411 | Regulation of insulin secretion: a matter of phase control and amplitude modulation |
| Q27335435 | Release of luminal exosomes contributes to TLR4-mediated epithelial antimicrobial defense |
| Q38230799 | Relevance of microRNA in metabolic diseases. |
| Q47700908 | Resveratrol attenuates type 2 diabetes mellitus by mediating mitochondrial biogenesis and lipid metabolism via Sirtuin type 1. |
| Q92542988 | Role of TGF-β/Smad Pathway in the Transcription of Pancreas-Specific Genes During Beta Cell Differentiation |
| Q39032370 | Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus |
| Q37097895 | Role of microRNAs in diabetes |
| Q37953896 | Role of microRNAs in diabetes and its cardiovascular complications. |
| Q26995308 | Role of microRNAs in islet beta-cell compensation and failure during diabetes |
| Q41873853 | Role of microRNAs in obesity and obesity-related diseases |
| Q36348482 | Role of microRNAs in the age-associated decline of pancreatic beta cell function in rat islets |
| Q37735780 | Role of microRNAs in the treatment of type 2 diabetes mellitus with Roux-en-Y gastric bypass |
| Q38199221 | Role of non-coding RNAs in pancreatic beta-cell development and physiology |
| Q99561822 | Roles of Noncoding RNAs in Islet Biology |
| Q64227216 | Serum Exosomal miRNAs Are Associated with Active Pulmonary Tuberculosis |
| Q38951150 | Shaping and preserving β-cell identity with microRNAs |
| Q44105832 | Single-nucleotide polymorphisms inside microRNA target sites influence the susceptibility to type 2 diabetes |
| Q35400880 | Targeting microRNAs in obesity |
| Q38187862 | Targeting the pancreatic β-cell to treat diabetes |
| Q33515025 | The GTPase RalA regulates different steps of the secretory process in pancreatic beta-cells |
| Q26797469 | The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential |
| Q38194186 | Type 2 diabetes mellitus-related genetic polymorphisms in microRNAs and microRNA target sites. |
| Q38937712 | Understanding Genetic Heterogeneity in Type 2 Diabetes by Delineating Physiological Phenotypes: SIRT1 and its Gene Network in Impaired Insulin Secretion. |
| Q24609475 | VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA |
| Q86137270 | miR-101a and miR-30b contribute to inflammatory cytokine-mediated β-cell dysfunction |
| Q50791809 | miR-124a expression contributes to the monophasic pattern of insulin secretion in islets from pregnant rats submitted to a low-protein diet. |
| Q42630537 | miR-204 is associated with an endocrine phenotype in human pancreatic islets but does not regulate the insulin mRNA through MAFA. |
| Q35139405 | miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1) |
| Q41899866 | miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors. |
| Q38600595 | miRNAs: early prognostic biomarkers for Type 2 diabetes mellitus? |
| Q42546741 | miR‑433 protects pancreatic β cell growth in high‑glucose conditions |
| Q96431014 | microRNA-181c-5p promotes the formation of insulin-producing cells from human induced pluripotent stem cells by targeting smad7 and TGIF2 |
| Q86900148 | microRNAs in Pancreatic β-Cell Physiology |
| Q38375953 | microRNAs with different functions and roles in disease development and as potential biomarkers of diabetes: progress and challenges |
| Q26780370 | β-Cell MicroRNAs: Small but Powerful |
Search more.